Pharmaxis anti-fibrotic pipeline review highlights drug with strong pre-clinical data for bone marrow cancer myelofibrosis
G Medical Innovations eyes significant revenue growth in the UK and US
Imugene targets defender B-cells with cancer vaccines HER-Vaxx and B-Vaxx
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.